• Activity INFORMATION

  Overview

  It is imperative for pharmacy practitioners to always be aware of new drug approvals and changes in the pharmacy industry. Even under the shadow of the COVID-19 pandemic, innovative drugs for many other conditions were FDA approved. This program seeks to shine a spotlight onto the new treatment options approved for use during 2020. 
  

  Handouts

  • Slide Document :   20295H01_6pp.pdf Download

  • Slide Document :   20295H01_2pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recognize the approved indication, common adverse effects and drug interactions for new drugs approved by the FDA in 2020.

  Identify important drug alerts by the FDA (Public Health Advisories) and implications for patient care.

  For each new medication approved in 2020, identify the burden-to-benefit ratio of therapy.

  Pharmacy Technician

  Recognize the approved indication, common adverse effects and drug interactions for new drugs approved by the FDA in 2020.

  Identify important drug alerts by the FDA (Public Health Advisories) and implications for patient care.

  For each new medication approved in 2020, identify the burden-to-benefit ratio of therapy.

  Nurse

  Identify important drug alerts by the FDA (Public Health Advisories) and implications for patient care.

  For each new medication approved in 2020, identify the burden-to-benefit ratio of therapy.

  Recognize the approved indication, common adverse effects and drug interactions for new drugs approved by the FDA in 2020.

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-830134

  Universal Activity Number

  Pharmacist 0798-0000-20-295-H01-P
  Pharmacy Technician 0798-0000-20-295-H01-T
  Nurse 0798-0000-20-295-H01-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Mary Lynn  McPherson, PharmD, PhD, BCPS, FAAHPM Professor and Executive Director, Advanced Post-Graduate Education in Palliative Care, University of Maryland School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).